Guardant Health, Inc. - Common Stock (GH)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock
Shares outstanding
123,850,680
Number of holders
399
Total 13F shares, excl. options
87,374,557
Shares change
+1,662,654
Total reported value, excl. options
$11,260,127,731
Value change
+$219,249,861
Put/Call ratio
90%
Number of buys
251
Number of sells
111
Price
$128.88

Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q4 2020

As of 31 Dec 2020 Guardant Health, Inc. - Common Stock (GH) had 467 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 87,374,557 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, SB INVESTMENT ADVISERS (UK) LTD, BlackRock Inc., MORGAN STANLEY, VIKING GLOBAL INVESTORS LP, Clearbridge Investments, LLC, JENNISON ASSOCIATES LLC, FMR LLC, FRED ALGER MANAGEMENT, LLC, and Nuveen Asset Management, LLC.
This table shows 467 institutional shareholders of the security as of 31 Dec 2020.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.